As part of 𝗣𝗛𝗔π—₯𝗠𝗔 π—˜π—«π—£π—₯π—˜π—¦π—¦β€™ commitment to support product transportation safety and efficiency by our transporter vans, the company has put in place a robust fleet acquisition scheme by constantly renewing its fleet of transporter vehicles.

𝗣𝗛𝗔π—₯𝗠𝗔 π—˜π—«π—£π—₯π—˜π—¦π—¦β€™ investment in the purchase of the new fleet of transporters is to ensure that transportation of pharma products, of vaccines, of medicine, of genetic samples, of cosmetics, and not only products, around the European Union is safer and more efficient. Another main objective of this transporter acquisition scheme is to further ensure continuous improvement of its Health, Safety, Security and Environment (HSSE) standards. Due to the sensitive nature of the pharma industry it operates in and its products market, for 𝗣𝗛𝗔π—₯𝗠𝗔 π—˜π—«π—£π—₯π—˜π—¦π—¦ safety has to always come first.

Delivering the tools for Healing all over Europeβ€οΈβ€πŸ©Ή

𝗣𝗛𝗔π—₯𝗠𝗔 π—˜π—«π—£π—₯π—˜π—¦π—¦

+40 741 792 723

co*****@tr*************.com

www.transcom-pharma.com/en

#pharmaexpressspedition #pharmatransport #transcomdanmar